Misdiagnosing renal amyloidosis as minimal change disease.

BACKGROUND Minimal change disease (MCD) accounts for 10-15% of all adult nephrotic syndrome cases and requires normal renal histology by light microscopy and negative immunohistology. Foot process effacement on electron microscopy (EM) is typical. Renal amyloid deposits demonstrate pathognomonic green birefringence when viewed under cross-polarized light after staining tissue with Congo red (CR) and may reveal fibrils on EM. Late diagnosis and delayed treatment of renal amyloidosis negatively impact on renal and patient survival. METHODS A retrospective analysis was performed on 2116 patients referred to the National Amyloidosis Centre between 2001 and 2013, in whom renal amyloidosis was confirmed histologically. Twenty-seven of these patients had renal histology initially interpreted to be MCD. RESULTS Among 26 patients in whom biopsy specimens and/or reports were retrieved, the median age at MCD diagnosis was 62 years and presenting proteinuria averaged 7.8 g/24 h. The median time period between the two diagnoses was 241 days (range: 20-2632 days). MCD was diagnosed without CR in 17/26 (65%) biopsies, but all specimens contained amyloid on retrospective CR staining. MCD was diagnosed without EM in 17/26 (65%) cases and all of 10 such biopsies subsequently demonstrated fibrils. Sixteen patients were subjected to two or more renal biopsies when their proteinuria proved steroid refractory. CONCLUSION This study highlights the need to stain renal biopsies from proteinuric adults with CR, examine them under cross-polarized light and perform EM wherever possible. If the suspicion of renal amyloidosis remains high, despite apparent negative histology, specimens should be reviewed at specialist centres before undertaking a second kidney biopsy.

[1]  Ahmet Dogan,et al.  Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[2]  J. Moon,et al.  Updates in Cardiac Amyloidosis: A Review , 2012, Journal of the American Heart Association.

[3]  P. Hawkins,et al.  Outcome in renal Al amyloidosis after chemotherapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Caroline A Sabin,et al.  Natural history and outcome in systemic AA amyloidosis. , 2007, The New England journal of medicine.

[5]  V. D’Agati,et al.  Adult minimal-change disease: clinical characteristics, treatment, and outcomes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[6]  L. Dember Amyloidosis-associated kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  K. Uhlig,et al.  AL-amyloidosis of the kidney initially presenting as minimal change glomerulonephritis. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  B. Brenner Brenner and Rector's The Kidney , 2000 .

[9]  John Feehally,et al.  Comprehensive Clinical Nephrology , 2000 .

[10]  L. Lovat,et al.  The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients , 1998, Gut.

[11]  Nadine Bazilinski,et al.  Brenner and Rector's The Kidney , 1997 .

[12]  M. Pepys,et al.  Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. , 1990, The New England journal of medicine.

[13]  B. Jones,et al.  Minimal renal amyloidosis with nephrotic syndrome. , 1986, Archives of pathology & laboratory medicine.

[14]  D. Brigger,et al.  Comparison of Sirius red and Congo red as stains for amyloid in animal tissues. , 1975, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .

[16]  B. Moulin,et al.  CHAPTER 26 – Renal Amyloidosis and Glomerular Diseases with Monoclonal Immunoglobulin Deposition , 2010 .

[17]  J. Floege,et al.  CHAPTER 15 – Introduction to Glomerular Disease: Clinical Presentations , 2010 .

[18]  R. Falk Primary glomerular disease , 2004 .